This inventor holds 1 USPTO granted patent. Top assignee: Beijing Normal University. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Jiuyi Li: Innovator in Molecular Typing of Multiple Myeloma.
Introduction
Jiuyi Li is a prominent inventor based in Beijing, China. He has made significant contributions to the field of molecular biology, particularly in the diagnosis and treatment of multiple myeloma. His innovative work focuses on the molecular typing of this complex disease, which is crucial for improving patient outcomes.
Latest Patents
Jiuyi Li holds a patent titled "Molecular typing of multiple myeloma and application." This patent discloses a product that includes a substance for obtaining or detecting 97 gene expressions in multiple myeloma patients. The invention also features an apparatus designed to operate a multiple myeloma Bayesian classifier. By utilizing this product, the invention identifies a gene module co-expressed with the MCL1 gene, which helps distinguish molecular subtypes of multiple myeloma that have varying prognoses and sensitivities to bortezomib.
Career Highlights
Throughout his career, Jiuyi Li has focused on advancing the understanding of multiple myeloma through innovative research and development. His work has the potential to transform how this disease is diagnosed and treated, ultimately benefiting patients and healthcare providers alike.
Collaborations
Jiuyi Li has collaborated with notable colleagues, including Xiaolong Fan and Ayaz Ali Samo. These partnerships have enhanced the research and development of his patented technologies, contributing to the advancement of molecular typing in multiple myeloma.
Conclusion
Jiuyi Li's contributions to the field of molecular typing of multiple myeloma represent a significant advancement in medical science. His innovative patent and collaborative efforts are paving the way for improved diagnostic and therapeutic strategies for patients suffering from this challenging disease.